Fig. 1: Mount Sinai COVID-19 biobank workflow and collection timeline.
From: Sampling the host response to SARS-CoV-2 in hospitals under siege
a, Mount Sinai COVID-19 biobank workflow. The workflow involved six teams of research personnel. First, the screening team identified eligible patients and notified the assembly and consenting teams. The assembly team then created study kits while the nurse outreach team engaged with the clinical staff. Once kits were assembled, the running team distributed kits to and collected kits from the clinical staff. Finally, the running team transported filled kits to the processing team. EMR, electronic medical records; PPE, personal protective equipment; CPT, cell-preparation tube; SST, serum-separator tube; CyTOF, cytometry by time of flight; RNAseq, RNA sequencing; WES, whole-exome sequencing; CITEseq, cellular indexing of transcriptomes and epitopes by sequencing. b, Timeline of Mount Sinai COVID-19 biobank collection. Bars indicate the number of people (vertical axis) hospitalized with COVID-19 in the Mount Sinai Health System (MSHS) or enrolled in the biobank (cumulative) at a given time point (horizontal axis).
